ACAndres Fernandez del Castillo

Andres Fernandez del Castillo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Andres Fernandez del Castillo has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Titelbild: Hydroxylierte Aryl‐Tetrazine als bioorthogonale Scheren zur systematischen Spaltung von trans‐Cyclooctenen (Angew. Chem. 5/2025)

    by Martin Wilkovitsch, Walter Kuba, Patrick Keppel, Barbara Sohr, Andreas Löffler, Stefan Kronister, Andres Fernandez del Castillo, Marion Goldeck, Rastislav Dzijak, Michal Rahm, et al.

  • Cover Picture: Transforming Aryl‐Tetrazines into Bioorthogonal Scissors for Systematic Cleavage of trans‐Cyclooctenes (Angew. Chem. Int. Ed. 5/2025)

    by Martin Wilkovitsch, Walter Kuba, Patrick Keppel, Barbara Sohr, Andreas Löffler, Stefan Kronister, Andres Fernandez del Castillo, Marion Goldeck, Rastislav Dzijak, Michal Rahm, et al.

  • Open Access

    Hydroxylierte Aryl‐Tetrazine als bioorthogonale Scheren zur systematischen Spaltung von trans‐Cyclooctenen

    by Martin Wilkovitsch, Walter Kuba, Patrick Keppel, Barbara Sohr, Andreas Löffler, Stefan Kronister, Andres Fernandez del Castillo, Marion Goldeck, Rastislav Dzijak, Michal Rahm, et al.

    Bioorthogonale Bindungsspaltungsreaktionen haben sich als leistungsstarke Werkzeuge für die präzise zeitliche und räumliche Kontrolle (bio)molekularer Funktionen in biologischen Systemen etabliert. Unter diesen sticht die durch Click‐Reaktion mit Tetrazinen ausgelöste Eliminierung spaltbarer trans‐Cyclooctene (Click‐Spaltung, engl. Click‐to‐Release) aufgrund hoher Reaktionsraten sowie ihrer Vielseitigkeit und Selektivität hervor. Trotz des zunehmenden Verständnisses der zugrunde liegenden Mechanismen ist die Anwendung dieser Reaktion aufgrund unzureichender Eigenschaften (Click‐Kinetik, Spaltungskinetik, Spaltungseffizienz) der bestehenden Reagenzien eingeschränkt. Eine effiziente Spaltung war bisher auf Tetrazine mit vergleichsweise niedriger Click‐Reaktivität beschränkt, während hochreaktive Aryl‐Tetrazine nur eine minimale Spaltung erzielen. Durch die Einführung von Hydroxylgruppen an Phenyl‐ und Pyridyl‐Tetrazinen ist es uns gelungen, eine neue Klasse von ′bioorthogonalen Scheren′ mit hoher chemischer Leistungsfähigkeit zu entwickeln. Diese Hydroxyaryl‐Tetrazine erreichen eine nahezu quantitative Spaltung nach beschleunigter Click‐Reaktion mit unterschiedlichen spaltbaren trans‐Cyclooctenen, was durch die Click‐ausgelöste Aktivierung einer Wirkstoffvorstufe (engl. Prodrug), die intramitochondriale Spaltung einer fluorogenen Sonde in lebenden Zellen und die schnelle intrazelluläre bioorthogonale Spaltung eines Ligand‐Farbstoff‐Konjugats demonstriert wird.


  • Open Access

    Transforming Aryl‐Tetrazines into Bioorthogonal Scissors for Systematic Cleavage of trans‐Cyclooctenes

    by Martin Wilkovitsch, Walter Kuba, Patrick Keppel, Barbara Sohr, Andreas Löffler, Stefan Kronister, Andres Fernandez del Castillo, Marion Goldeck, Rastislav Dzijak, Michal Rahm, et al.

    Bioorthogonal bond‐cleavage reactions have emerged as a powerful tool for precise spatiotemporal control of (bio)molecular function in the biological context. Among these chemistries, the tetrazine‐triggered elimination of cleavable trans‐cyclooctenes (click‐to‐release) stands out due to high reaction rates, versatility, and selectivity. Despite an increasing understanding of the underlying mechanisms, application of this reaction remains limited by the cumulative performance trade‐offs (i.e., click kinetics, release kinetics, release yield) of existing tools. Efficient release has been restricted to tetrazine scaffolds with comparatively low click reactivity, while highly reactive aryl‐tetrazines give only minimal release. By introducing hydroxyl groups onto phenyl‐ and pyridyl‐tetrazine scaffolds, we have developed a new class of ‘bioorthogonal scissors’ with unique chemical performance. We demonstrate that hydroxyaryl‐tetrazines achieve near‐quantitative release upon accelerated click reaction with cleavable trans‐cyclooctenes, as exemplified by click‐triggered activation of a caged prodrug, intramitochondrial cleavage of a fluorogenic probe (turn‐on) in live cells, and rapid intracellular bioorthogonal disassembly (turn‐off) of a ligand‐dye conjugate.


  • Open Access

    Transforming Aryl-Tetrazines into Bioorthogonal Scissors for Systematic Cleavage of trans-Cyclooctenes

    by Martin Wilkovitsch, Walter Kuba, Patrick Keppel, Barbara Sohr, Andreas Löffler, Stefan Kronister, Andres Fernandez del Castillo, Marion Goldeck, Rastislav Dzijak, Michal Rahm, et al.

    Bioorthogonal bond-cleavage reactions have emerged as a powerful tool for precise spatiotemporal control of (bio)molecular function in the biological context. Among these chemistries, the tetrazine-triggered elimination of cleavable trans-cyclooctenes (click-to-release) stands out due to high reaction rates, versatility, and selectivity. Despite an increasing understanding of the underlying mechanisms, application of this reaction remains limited by the cumulative performance trade-offs (i.e., click kinetics, release kinetics, release yield) of existing tools. Efficient release has been restricted to tetrazine scaffolds with comparatively low click reactivity, while highly reactive aryl-tetrazines give only minimal release. By introducing hydroxyl groups onto phenyl- and pyridyl-tetrazine scaffolds, we have developed a new class of ‘bioorthogonal scissors’ with unique chemical performance. We demonstrate that hydroxyaryl-tetrazines achieve near-quantitative release upon accelerated click reaction with cleavable trans-cyclooctenes, as exemplified by click-triggered activation of a caged prodrug, intramitochondrial cleavage of a fluorogenic probe (turn-on) in live cells, and rapid intracellular bioorthogonal disassembly (turn-off) of a ligand-dye conjugate.


  • Open Access

    Single-cell barcode analysis provides a rapid readout of cellular signaling pathways in clinical specimens

    by Randy J. Giedt, Divya Pathania, Jonathan C. T. Carlson, Philip J. McFarland, Andres Fernandez del Castillo, Dejan Juric, Ralph Weissleder

    Serial tissue sampling has become essential in guiding modern targeted and personalized cancer treatments. An alternative to image guided core biopsies are fine needle aspirates (FNA) that yield cells rather than tissues but are much better tolerated and have lower complication rates. The efficient pathway analysis of such cells in the clinic has been difficult, time consuming and costly. Here we develop an antibody-DNA barcoding approach where harvested cells can be rapidly re-stained through the use of custom designed oligonucleotide-fluorophore conjugates. We show that this approach can be used to interrogate drug-relevant pathways in scant clinical samples. Using the PI3K/PTEN/CDK4/6 pathways in breast cancer as an example, we demonstrate how analysis can be performed in tandem with trial enrollment and can evaluate downstream signaling following therapeutic inhibition. This approach should allow more widespread use of scant single cell material in clinical samples.


  • Top Cited Papers

    Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy

    by Katherine S. Yang, Hyungsoon Im, Seonki Hong, Ilaria Pergolini, Andres Fernandez del Castillo, Rui Wang, Susan Clardy, Chen-Han Huang, Craig Pille, Soldano Ferrone, et al.

    Pancreatic ductal adenocarcinoma (PDAC) is usually detected late in the disease process. Clinical workup through imaging and tissue biopsies is often complex and expensive due to a paucity of reliable biomarkers. We used an advanced multiplexed plasmonic assay to analyze circulating tumor-derived extracellular vesicles (tEVs) in more than 100 clinical populations. Using EV-based protein marker profiling, we identified a signature of five markers (PDACEV signature) for PDAC detection. In our prospective cohort, the accuracy for the PDACEV signature was 84% [95% confidence interval (CI), 69 to 93%] but only 63 to 72% for single-marker screening. One of the best markers, GPC1 alone, had a sensitivity of 82% (CI, 60 to 95%) and a specificity of 52% (CI, 30 to 74%), whereas the PDACEV signature showed a sensitivity of 86% (CI, 65 to 97%) and a specificity of 81% (CI, 58 to 95%). The PDACEV signature of tEVs offered higher sensitivity, specificity, and accuracy than the existing serum marker (CA 19-9) or single–tEV marker analyses. This approach should improve the diagnosis of pancreatic cancer.